XMD

Proton DEX Revolutionizes DeFi With True Decentralization That Gives Customers Control Of Digital Assets At All Times

Retrieved on: 
Wednesday, November 16, 2022
Technology, Finance, Fintech, Banking, Professional Services, Digital Cash Management, Digital Assets, Blockchain, Software, Cryptocurrency, MTL, Treaty of Dappes, Metal, Decentralized finance, USDC, Farm, TUSD, FIDO, Blockchain, APY, URL, CEX, USDP, Trade, XMD, DEX, Risk, Cryptocurrency, Metallicus, Proton

Proton DEX puts true decentralization into DeFi, said Marshall Hayner, Founder and CEO of Metallicus.

Key Points: 
  • Proton DEX puts true decentralization into DeFi, said Marshall Hayner, Founder and CEO of Metallicus.
  • You are in control of your cryptocurrency at all times, which eliminates the threat that a middleman could withhold funds from you.
  • Proton DEX users will be able to mint XMD for the Proton DEX at metaldollar.com.
  • Proton DEX is truly a one-stop shop for everything customers could possibly need for crypto trading on Proton Blockchain.

Florida’s Palm Vascular Centers is the First Healthcare Organization to Install XenFI, the Recently Announced Wireless Medical Ecosystem from Xenter

Retrieved on: 
Wednesday, November 2, 2022
Technology, Mobile, Wireless, Health Technology, Software, Networks, Other Health, Internet, Health, Data Management, Info, Interventions, MD, Publication, CEO, Partnership, Joe Byrd (Cherokee Nation Principal Chief), Clinical trial, Moyamoya disease, Beasley, Documentation, Organization, ML, NIH, Amputation, Physician, Industry, Mount Sinai Medical Center, Ecosystem, Wilford Hall Ambulatory Surgical Center, CLI, University, PAD, Medicare, Theory of multiple intelligences, XMD, Sudarshan K. Aggarwal, Patient, Artificial intelligence, Machine learning, Aneurysm, Multimedia, 3D ultrasound, National, EEG microstates, Mount Sinai Medical Center (Miami), Society, Wake Forest School of Medicine, Jacqueline Oble, Pharmaceutical industry, Medical device, Medicine, Medical imaging

The author of numerous publications in peer-reviewed medical journals, his work has been presented at more than 100 regional, national, and international medical meetings.

Key Points: 
  • The author of numerous publications in peer-reviewed medical journals, his work has been presented at more than 100 regional, national, and international medical meetings.
  • Palm Vascular treats a myriad of vascular conditions today and is the first vascular lab in South Florida with locations in multiple counties.
  • Xenter has launched a wireless Technology in Medicine (TechMed) ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients.
  • Xenter, XenFI, XMD, and Physical Intelligence are trademarks, of Xenter, Inc. All other trademarks and copyrights are property of their respective owners.

Xenter, the World's First "TechMed" Company, Unveils the XenFI Wireless Network

Retrieved on: 
Wednesday, October 5, 2022
Adoption, Physician, Laboratory, Technology, South Asian Institute of Technology and Medicine, Theory of multiple intelligences, Organization, Silicon, Patient, Office, Multimedia, Artificial intelligence, XMD, Learning, 3D ultrasound, Wilford Hall Ambulatory Surgical Center, CEO, Ecosystem, View, Medical device, Medicine, Jacqueline Oble

XenFIis comprised of XMD (a HIPAA-compliant, global healthcare cloud) and its XenFI-Hub, Xenter's wireless communications device that is designed for use in various healthcare settings.

Key Points: 
  • XenFIis comprised of XMD (a HIPAA-compliant, global healthcare cloud) and its XenFI-Hub, Xenter's wireless communications device that is designed for use in various healthcare settings.
  • These first Xenter products are designed to automate clinical workflow, enable smart/wireless devices, improve patient outcomes, and lower healthcare costs.
  • "Historically, the healthcare industry has been slow to adopt new technologies," said Richard J. Linder, Xenter's CEO, Chairman, and Founder.
  • "XenFI, XenFI-Hub and XMD are the first in a series of new products that can collect, aggregate, and analyze real-time Physical Intelligence data."

xMD Diagnostics, Inc. Awarded Competitive Innovation Grant from the National Science Foundation to Fund Coronavirus Precision Medicine Project

Retrieved on: 
Monday, August 23, 2021
Biotechnology, Infectious Diseases, Health, Science, Research, Infection, PCR, Cancer, Partnership, Engineering, XMD, Small business, Thought, Science, National Science Foundation, Coronavirus, Research, NSF, Division, R, Marie Cassidy, Department of Industry, Innovation, Science, Research and Tertiary Education, Small Business Innovation Research, Hospital, Public health, Food, SBIR, Patient, Solution, Education, NGS, Water, Lists of diseases, Technology, MD, Pharmaceutical industry, xMD Diagnostics, Inc. (xMD): x, the National Science Foundation's Small Business Programs:, XMD DIAGNOSTICS, INC. (XMD): X, THE NATIONAL SCIENCE FOUNDATION'S SMALL BUSINESS PROGRAMS:

xMD Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development work to improve the reliability of coronavirus detection from patient samples.

Key Points: 
  • xMD Diagnostics, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $256,000 to conduct research and development work to improve the reliability of coronavirus detection from patient samples.
  • The SBIR grant is highly competitive, with fewer than 13% of applications ultimately earning an award.
  • xMD Diagnostics will use their proprietary tissue purification technology to develop a method that will increase the purity of coronavirus patient saliva samples.
  • We are thrilled to be the recipients of a coveted NSF SBIR grant, stated xMD Diagnostics Inc. CEO Ting-Pau Oei.